Sign up
Quantellect · Analysts · Analyst Profile
Analyst Score Rank#357 of 589

Li Watsek

Cantor Fitzgerald · Equity Research Analyst
ProvisionalRating since 2021No new ratings since Oct 2025

Analyst rating accuracy & track record

Li Watsek is an equity research analyst at Cantor Fitzgerald. Quantellect has scored 32 of their stock calls across 14 companies. Their picks beat their sector 38% of the time over the next 12 months, and their price targets were reached — of the time within a year.

Win % vs sector
38%
PT Hit % (12mo)
—
Avg sector-excess
−7.8%
Scored calls
32
Tickers
14
Tier
Provisional

Track record

Quantellect has scored 32 of Li Watsek's stock calls across 14 companies, dating back to 2021. Their rated stocks beat their own sector 38% of the time over the next 12 months. On a typical call, a Watsek pick returned −7.8% more than its sector over the following year.

Of the scored calls, 32 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
ASNDAscendis Pharma AS
Buy$254.00Oct 2025−13.2%Hit
RCUSArcus Biosciences Inc
Buy—Oct 2025+39.6%—
CNTXContext Therapeutics Inc
Buy—Oct 2025−87.5%—
CNTXContext Therapeutics Inc
Buy—Oct 2025−87.5%—
ARVNArvinas Inc
Buy—Sep 2025−13.5%—
IDYAIdeaya Biosciences Inc
Buy—Sep 2025+32.3%—
IDYAIdeaya Biosciences Inc
Buy—Sep 2025+32.3%—
IDYAIdeaya Biosciences Inc
Buy—Sep 2025+32.3%—
ASNDAscendis Pharma AS
Buy$203.00Aug 2025−0.5%Hit
REPLReplimune Group Inc
Buy—Jul 2025−50.0%—
KURAKura Oncology Inc
Buy—Jun 2025+71.0%—
KURAKura Oncology Inc
Buy—Jun 2025+71.0%—
REPLReplimune Group Inc
Buy—Jun 2025+6.1%—
CRVSCorvus Pharmaceuticals Inc
Buy—Jun 2025+169.7%—
ZLABZai Lab Ltd
Buy—Mar 2025−52.6%—
ACRVAcrivon Therapeutics, Inc. Common Stock
Buy—Mar 2025−46.0%—
TARAProtara Therapeutics Inc
Buy—Mar 2025+17.9%—
ACRVAcrivon Therapeutics, Inc. Common Stock
Buy—Jan 2025−75.0%—
ALXOAlx Oncology Holdings 
Buy—Jan 2025−13.9%—
ALXOAlx Oncology Holdings 
Buy—Dec 2024−19.7%—
KURAKura Oncology Inc
Buy—Dec 2024−2.2%—
KURAKura Oncology Inc
Buy—Nov 2024−2.4%—
ALXOAlx Oncology Holdings 
Buy—Nov 2024−10.4%—
ALXOAlx Oncology Holdings 
Buy—Aug 2024−64.9%—
ALXOAlx Oncology Holdings 
Buy—May 2024−90.6%—
Prev1
Go to

Li Watsek: analyst track record FAQ

Is Li Watsek a good stock analyst?

Yes, by track record. Li Watsek ranks number 357 of 589 of the analysts Quantellect scores, with an Analyst Score of 27 out of 100. Past results do not guarantee future ones.

What is Li Watsek's win rate?

Li Watsek's win rate is 38%. Across 32 scored calls, their rated stocks beat their sector 38% of the time over the next 12 months. On a typical call they returned −7.8% more than the sector.

What stocks and sectors does Li Watsek cover?

Li Watsek covers 14 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Li Watsek's price targets accurate?

Li Watsek's price targets are reached within 12 months — of the time. The base rate across all analysts Quantellect tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Quantellect scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Li Watsek's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Quantellect score analyst accuracy?

Quantellect scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Li Watsek rank among Wall Street analysts?

Li Watsek ranks number 357 of 589 by Analyst Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Quantellect calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.